PlumX Metrics
Embed PlumX Metrics

Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: What is the evidence?

Neural Regeneration Research, ISSN: 1876-7958, Vol: 19, Issue: 3, Page: 536-541
2024
  • 2
    Citations
  • 0
    Usage
  • 12
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: what is the evidence?

Neural Regen Res. 2024 Mar;19(3):536-541. Authors: Jourdi G, Fleury S, Boukhatem I, Lordkipanidzé M PubMed: 37721281 Submit Comment

Review Description

Neurodegenerative diseases are often misdiagnosed, especially when the diagnosis is based solely on clinical symptoms. The p75 neurotrophic receptor (p75 NTR) has been studied as an index of sensory and motor nerve development and maturation. Its cleavable extracellular domain (ECD) is readily detectable in various biological fluids including plasma, serum and urine. There is evidence for increased p75 NTR ECD levels in neurodegenerative diseases such as Alzheimer's disease, amyotrophic lateral sclerosis, age-related dementia, schizophrenia, and diabetic neuropathy. Whether p75 NTR ECD could be used as a biomarker for diagnosis and/or prognosis in these disorders, and whether it could potentially lead to the development of targeted therapies, remains an open question. In this review, we present and discuss published studies that have evaluated the relevance of this emerging biomarker in the context of various neurodegenerative diseases. We also highlight areas that require further investigation to better understand the role of p75 NTR ECD in the clinical diagnosis and management of neurodegenerative disorders.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know